跳至主要内容
临床试验/NCT01509248
NCT01509248Unknown不适用

Population Pharmacokinetics and Metabolomic Analysis of Aminopylline/Theophylline Drug Levels in Preterm Infants With Apnea of Prematurity

Seoul National University Hospital0 个研究点目标入组 110 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
110

研究概览

简要总结

  1. Population pharmacokinetics : The purpose of this study is
  • to investigate the population pharmacokinetics of theophylline in premature Korean infants and to assess the influence of demographic and clinical covariates.
  1. Metabolomics : The purpose of this study are
  • to predict serum theophylline levels and to assess CYP1A2 activities in premature infants by analyzing urinary metabolites of theophylline
  • to examine which factors affect clearance of theophylline and CYP1A2 activity in premature infants

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 37 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Inborn preterm infants (GA < 37 weeks)
  • Dx : Apnea of prematurity
  • Tx : Aminophylline / Theophylline
  • Informed consent of parents

排除标准

  • Major congenital anomaly
  • Expired within 72 hours
  • Proven secondary apnea

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Han-Suk Kim

Associate Professor & Director of Neonatal Intensive Care Unit

Seoul National University Hospital

相似试验

Population Pharmacokinetics and Metabolomics of... | 临床试验